Tilray Stocks Stuck in Neutral as Losses Weigh on Record Revenue

Tilray Brands' stock has been trading below $5 despite posting record fiscal revenue of $915 million in 2026. However, investors are hesitant to give the company the benefit of the doubt due to its ongoing losses and history in the marijuana industry.

The company's management is focusing on adding other products to its portfolio, including alcoholic beverages and CBD-infused items, with the goal of becoming a global lifestyle and consumer packaged goods company. This shift marks a significant departure from its initial focus as a marijuana company.

Despite this diversification effort, Tilray's market cap remains relatively small at $600 million, making it difficult to compete with larger companies in the consumer staples industry. The company's revenue is still a rounding error compared to industry giants like Coca-Cola, which generated over $13 billion in sales in just one quarter of 2026.